Patients receiving cancer treatment could increase their chances of survival by up to 20% and help stop the spread of cancer with a low dose of aspirin, research by the University of California School of Medicine suggests. Cardiff (United Kingdom) and collected by PloS One magazine. The benefits of aspirin seem not to decrease in recent times.
The researchers conducted a systematic review of all the available scientific literature (randomized trials and 42 studies), discovering a significant reduction in mortality and cancer in patients who had taken a low-level dose of aspirin in addition to their anti-drug treatment. cancer (data were analyzed with a mean follow-up of more than 5 years).
“ There is growing evidence that taking aspirin has significant benefits in reducing some types of cancer. While we know that a low dose of aspirin has been shown to reduce the incidence of cancer, its role in cancer treatment remains uncertain. As a result, we set out to carry out a systematic search of the entire scientific literature , ”says Peter Elwood, leader of the study.
According to the conclusions of the study, low doses of aspirin in patients with colon, breast or prostate cancer were associated with a reduction in deaths of around 15-20% added to a decrease in the spread of cancer cells to other organs (metastasis).
“ One of the concerns about taking aspirin continues to be the possibility of intestinal bleeding. That is why we specifically searched for available evidence of bleeding and wrote to all authors to ask for more data. No studies reported life-threatening bleeding, ”Elwood clarifies.
